Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
editorial
. 2006 Aug;43(8):e44. doi: 10.1136/jmg.2005.040121

Reply to Dr Raux et al.: Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update (J Med Genet 2005;42:793–5)

A J Larner 1, M Doran 1
PMCID: PMC2649022  PMID: 16882738

In their recent article, Dr Raux and colleagues1 report eight new presenilin‐1 (PSEN1) mutations in autosomal dominant early onset Alzheimer's disease (AD), four of which are said to be at codons not previously reported as mutant in AD (codons 214, 386, 391, and 424).

In our review of PSEN1 mutations,2 we identified a previous report from Poland3 of a mutation (L424R) at codon 424, with earlier age at onset (30–35 years) than in the French pedigree (38–42 years). Of the novel mutations at codons previously reported mutant in AD (codons 105, 116, 143, and 206),1 two (T116I and G206S) produce predicted amino acid substitutions already reported. In an Italian patient with the T116I mutation, with age at onset of 45 years, there was no family history of AD and this was thought to represent a de novo mutation.4 The G206S mutation has been reported but without clinical details.5

It is important to compare the clinical phenotypes of families sharing the same mutation, to ascertain whether phenotypes are mutation specific, or whether there is clinical heterogeneity. If the latter, then this is a first step in looking for the sources of heterogeneity, both genetic and epigenetic.2

Footnotes

Competing interests: there are no competing interests

References

  • 1.Raux G, Guyant‐Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet 200542793–795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Larner A J, Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin‐1 gene. J Neurol 2006253139–158. [DOI] [PubMed] [Google Scholar]
  • 3.Kowalska A, Forsell C, Florczak J, Pruchnik‐Wolinska D, Modestowicz R, Paprzycki W, Wender M, Lannfelt L. A Polish pedigree with Alzheimer's disease determined by a novel mutation in exon 12 of the presenilin‐1 gene: clinical and molecular characterization. Folia Neuropathol 19993757–61. [PubMed] [Google Scholar]
  • 4.La Bella V, Liguori M, Cittadella R, Settipani N, Piccoli T, Manna I, Quattrone A, Piccoli F. A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early‐onset Alzheimer's disease. Eur J Neurol 200411521–524. [DOI] [PubMed] [Google Scholar]
  • 5.Rogaeva E A, Fafel K C, Song Y Q, Medeiros H, Sato C, Liang Y, Richard E, Rogaev E I, Frommelt P, Sadovnick A D, Meschino W, Rockwood K, Boss M A, Mayeux R, St George‐Hyslop P. Screening for PS1 mutations in a referral‐based series of AD cases. 21 novel mutations. Neurology 200157621–625. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES